The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Other research has shown red light therapy could minimize the appearance of wrinkles, hyperpigmentation, and broken blood ...

Welfare and Vulnerability Engagement (WAVE) training educates bar and pub staff on identifying potentially vulnerable customers, with the goal of curbing violent crime, sexual offences, and drug or ...

Susan Collins (Maine) and Lisa Murkowski (Alaska) expressed reservations about the HHS nominee’s record on vaccines.

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being. Traditional treatments often fall short, offering temporary relief at best while ...

An international trial identified three new, all-oral drug regimens for drug-resistant tuberculosis, improving treatment ...

If approved, Kennedy will control a $1.7 trillion agency that oversees food and hospital inspections, hundreds of health ...

Robert F. Kennedy Jr. was pressed to clarify his views on vaccines, abortion and public health priorities in the first of two ...

Democrats focused on Kennedy's anti-vaccine advocacy. Republicans probed the former Democratic leader on his abortion and ...